Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

New azole antifungals with a fused triazinone scaffold.

Montoir D, Guillon R, Gazzola S, Ourliac-Garnier I, Soklou KE, Tonnerre A, Picot C, Planchat A, Pagniez F, Le Pape P, Logé C.

Eur J Med Chem. 2020 Mar 1;189:112082. doi: 10.1016/j.ejmech.2020.112082. Epub 2020 Jan 20.

PMID:
32000050
2.

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.

Pagniez F, Lebouvier N, Na YM, Ourliac-Garnier I, Picot C, Le Borgne M, Le Pape P.

J Enzyme Inhib Med Chem. 2020 Dec;35(1):398-403. doi: 10.1080/14756366.2019.1705292.

3.

A Decade of Antifungal Leads from Natural Products: 2010-2019.

Aldholmi M, Marchand P, Ourliac-Garnier I, Le Pape P, Ganesan A.

Pharmaceuticals (Basel). 2019 Dec 12;12(4). pii: E182. doi: 10.3390/ph12040182. Review.

4.

Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: Synthesis and evaluation of fluconazole susceptibility restoration.

Dao VH, Ourliac-Garnier I, Bazin MA, Jacquot C, Baratte B, Ruchaud S, Bach S, Grovel O, Le Pape P, Marchand P.

Bioorg Med Chem Lett. 2018 Jul 15;28(13):2250-2255. doi: 10.1016/j.bmcl.2018.05.044. Epub 2018 May 23.

PMID:
29853332
5.

Telomere Strand-Specific Length Analysis by Fluorescent In Situ Hybridization (Q-CO-FISH).

Ourliac-Garnier I, Londoño-Vallejo A.

Methods Mol Biol. 2017;1587:41-54. doi: 10.1007/978-1-4939-6892-3_4.

PMID:
28324496
6.

Telomere Length Analysis by Quantitative Fluorescent in Situ Hybridization (Q-FISH).

Ourliac-Garnier I, Londoño-Vallejo A.

Methods Mol Biol. 2017;1587:29-39. doi: 10.1007/978-1-4939-6892-3_3.

PMID:
28324495
7.

Telomere strand-specific length analysis by fluorescent in situ hybridization (Q-CO-FISH).

Ourliac-Garnier I, Londoño-Vallejo A.

Methods Mol Biol. 2011;735:33-46. doi: 10.1007/978-1-61779-092-8_4.

PMID:
21461809
8.

Telomere length analysis by quantitative fluorescent in situ hybridization (Q-FISH).

Ourliac-Garnier I, Londoño-Vallejo A.

Methods Mol Biol. 2011;735:21-31. doi: 10.1007/978-1-61779-092-8_3.

PMID:
21461808
9.

Relationships linking amplification level to gene over-expression in gliomas.

Vogt N, Gibaud A, Almeida A, Ourliac-Garnier I, Debatisse M, Malfoy B.

PLoS One. 2010 Dec 8;5(12):e14249. doi: 10.1371/journal.pone.0014249.

10.

Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.

Ourliac-Garnier I, Poulet A, Charif R, Amiard S, Magdinier F, Rezaï K, Gilson E, Giraud-Panis MJ, Bombard S.

J Biol Inorg Chem. 2010 Jun;15(5):641-54. doi: 10.1007/s00775-010-0631-4. Epub 2010 Feb 27.

PMID:
20191372
11.

Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN.

Arnoult N, Saintome C, Ourliac-Garnier I, Riou JF, Londoño-Vallejo A.

Genes Dev. 2009 Dec 15;23(24):2915-24. doi: 10.1101/gad.544009.

12.

GG sequence of DNA and the human telomeric sequence react with cis-diammine-diaquaplatinum at comparable rates.

Ourliac Garnier I, Bombard S.

J Inorg Biochem. 2007 Mar;101(3):514-24. Epub 2006 Nov 21.

PMID:
17224184
13.

Cross-links of quadruplex structures from human telomeric DNA by dinuclear platinum complexes show the flexibility of both structures.

Ourliac-Garnier I, Elizondo-Riojas MA, Redon S, Farrell NP, Bombard S.

Biochemistry. 2005 Aug 9;44(31):10620-34.

PMID:
16060671

Supplemental Content

Loading ...
Support Center